A partial differential equation model of metastasized prostatic cancer

DOI10.3934/MBE.2013.10.591MaRDI QIDQ356925zbMATH OpenOpenAlexWikidataFDO

Authors A. Friedman, Harsh Vardhan Jain

Publication date 29 July 2013

Published in Mathematical Biosciences and Engineering (Search for Journal in Brave)

Copyright license Creative Commons Attribution 4.0 International

Full work available at URL https://doi.org/10.3934/mbe.2013.10.591

zbMATH Keywords

free boundary problemprostate cancerandrogen ablationPSA

Mathematics Subject Classification ID

Medical applications (general) (92C50) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Free boundary problems for PDEs (35R35)

Recommendations

• Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
• Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
• A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy
• Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects
• A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor

Cited in

(11)

• Correlation between animal and mathematical models for prostate cancer progression
• Long time dynamics of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects
• A numerical simulation study of the dual role of \(5\alpha\)-reductase inhibitors on tumor growth in prostates enlarged by benign prostatic hyperplasia via stress relaxation and apoptosis upregulation
• An alternative approach to modelling relapse in cancer with an application to adenocarcinoma of the prostate
• Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells
• An ordinary differential equation model for the multistep transformation to cancer
• Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects
• Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
• Solitary solutions to an androgen-deprivation prostate cancer treatment model
• Maximum bound principle and non-negativity preserving ETD schemes for a phase field model of prostate cancer growth with treatment
• An integrative model of prostate cancer interaction with the bone microenvironment

This page was built for publication: A partial differential equation model of metastasized prostatic cancer

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q356925)